AIM
BSX icon

Artemis Investment Management’s Boston Scientific BSX Stock Holding History

Artemis Investment Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-758,544
Closed -$32.2M – 267
2021
Q4 		$32.2M Sell
758,544
-105,922
-12% -$4.45M 0.23% 116
2021
Q3 		$37.5M Buy
864,466
+20,970
+2% +$928K 0.3% 99
2021
Q2 		$36.1M Buy
+843,496
New +$35.5M 0.31% 103
2020
Q4 		– Sell
-79,716
Closed -$3.04M – 255
2020
Q3 		$3.04M Sell
79,716
-2,633
-3% -$101K 0.04% 237
2020
Q2 		$2.89M Sell
82,349
-791,260
-91% -$28.5M 0.04% 233
2020
Q1 		$28.5M Sell
873,609
-886,912
-50% -$34.6M 0.05% 56
2019
Q4 		$79.5M Buy
1,760,521
+617,952
+54% +$25.9M 1.01% 25
2019
Q3 		$46.4M Buy
1,142,569
+557,120
+95% +$23.6M 0.63% 53
2019
Q2 		$25.1M Buy
585,449
+22,527
+4% +$866K 0.3% 105
2019
Q1 		$21.6M Sell
562,922
-134,081
-19% -$5.12M 0.25% 119
2018
Q4 		$24.6M Sell
697,003
-98,027
-12% -$3.56M 0.32% 94
2018
Q3 		$30.6M Sell
795,030
-1,468
-0.2% -$51.3K 0.34% 76
2018
Q2 		$26M Sell
796,498
-8,489
-1% -$256K 0.36% 77
2018
Q1 		$22M Buy
804,987
+60,574
+8% +$1.65M 0.34% 75
2017
Q4 		$18.5M Buy
744,413
+114,294
+18% +$3.15M 0.31% 83
2017
Q3 		$18.4M Buy
630,119
+3,927
+0.6% +$108K 0.38% 72
2017
Q2 		$17.4M Sell
626,192
-137,213
-18% -$3.64M 0.42% 59
2017
Q1 		$19M Buy
763,405
+56,143
+8% +$1.37M 0.51% 50
2016
Q4 		$15.3M Buy
707,262
+1,696
+0.2% +$37K 0.41% 53
2016
Q3 		$16.8M Buy
705,566
+10,780
+2% +$257K 0.47% 51
2016
Q2 		$16.2M Sell
694,786
-200,532
-22% -$4.34M 0.44% 61
2016
Q1 		$16.9M Buy
895,318
+175,191
+24% +$3.08M 0.42% 54
2015
Q4 		$13.3M Sell
720,127
-100,091
-12% -$1.79M 0.33% 69
2015
Q3 		$13.5M Buy
820,218
+3,115
+0.4% +$53.2K 0.4% 56
2015
Q2 		$14.5M Buy
817,103
+531,342
+186% +$9.5M 0.47% 43
2015
Q1 		$5.07M Sell
285,761
-796,691
-74% -$12.6M 0.2% 116
2014
Q4 		$14.3M Buy
1,082,452
+159,631
+17% +$2.04M 0.56% 42
2014
Q3 		$10.9M Buy
+922,821
New +$11.6M 0.55% 62

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.29B AUM 4.86% 1-Year Est. Return

Artemis Investment Management's BSX Position: Q1 2022 in Review

Artemis Investment Management sold out of Boston Scientific (BSX) in Q1 2022, closing a stake of 758,544 shares — an estimated $32.2M sold.

Artemis Investment Management first reported a position in BSX in Q3 2014 and held it in 28 quarters. The position peaked at $79.5M in Q4 2019. 904 funds tracked by Wall St. Rank hold BSX as of Q1 2022.

  • Artemis Investment Management reported no remaining Boston Scientific position as of Q1 2022 after selling out during the quarter.
  • Artemis Investment Management sold 758,544 Boston Scientific shares in Q1 2022, an estimated $32.2M.
  • Artemis Investment Management first reported a position in Boston Scientific in Q3 2014 and held it in 28 quarters.
  • Artemis Investment Management's Boston Scientific position peaked at $79.5M in Q4 2019.
  • 904 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2022.

Based on Artemis Investment Management's 13F filing for Q1 2022, filed 21 Apr 2022.